KyDo Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.2M

  • Investors
  • 4

KyDo Therapeutics General Information

Description

Developer of covalent-allosteric small molecule inhibitors designed to treat challenging cancer variants. The company's technology utilizes covalent-allosteric modulation, small-molecule inhibition, structure-based inhibitor design, protein X-ray crystallography, medicinal chemistry, and preclinical validation, enabling oncology patients to access precision therapies that overcome resistance mechanisms and minimize side effects.

Contact Information

Website
www.kydo-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Otto-Hahn-Strasse 15
  • 44227 Dortmund
  • Germany
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Otto-Hahn-Strasse 15
  • 44227 Dortmund
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KyDo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 16-Sep-2025 $5.2M Completed Generating Revenue
To view KyDo Therapeutics’s complete valuation and funding history, request access »

KyDo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KyDo Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
i&i Biotech Fund Venture Capital Minority
Khanu Management Venture Capital Minority
TU capital Venture Capital Minority
VORNvc Venture Capital Minority
To view KyDo Therapeutics’s complete investors history, request access »

KyDo Therapeutics FAQs

  • When was KyDo Therapeutics founded?

    KyDo Therapeutics was founded in 2024.

  • Where is KyDo Therapeutics headquartered?

    KyDo Therapeutics is headquartered in Dortmund, Germany.

  • What is the size of KyDo Therapeutics?

    KyDo Therapeutics has 4 total employees.

  • What industry is KyDo Therapeutics in?

    KyDo Therapeutics’s primary industry is Biotechnology.

  • Is KyDo Therapeutics a private or public company?

    KyDo Therapeutics is a Private company.

  • What is KyDo Therapeutics’s current revenue?

    The current revenue for KyDo Therapeutics is .

  • How much funding has KyDo Therapeutics raised over time?

    KyDo Therapeutics has raised $5.2M.

  • Who are KyDo Therapeutics’s investors?

    i&i Biotech Fund, Khanu Management, TU capital, and VORNvc have invested in KyDo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process